Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

mRCC: Patients survive longer at high-volume centers

Joshi SS et al. Euro Urol. 2018 Sep;74[3]:387-93.

Key clinical point: Patients with metastatic renal cell carcinoma had significantly longer survival when they were treated at higher-volume centers.

Major finding: Overall survival was significantly longer among patients treated at centers with a mean of 20 vs. 5 or 10 cases per year, across all cohorts.

Study details: A retrospective study of National Cancer Database data on 41,836 patients with mRCC treated from 2004 through 2013.

Disclosures: The investigators did not specify a study funding source. Dr. Geynisman reported having no conflicts of interest.

Read the article.

Citation:

Joshi SS et al. Euro Urol. 2018 Sep;74[3]:387-93.

This Week's Must Reads

Haplo-HCT shows viability in DLBCL, Dreger P et al. Blood Adv. 2019 Feb 12;3(3):360-9

First-line avelumab/axitinib for RCC benefits wide range of patients, Choueiri TK et al. GUCS 2019, Abstract 544.

President Trump requests $500 million for pediatric cancer, Trump D. State of the Union Address, Feb. 5, 2019.

Inadequate emergency care a challenge for rural pediatric patients, Walling EB et al. J Oncol Pract. 2019 Jan 31. doi: 10.1200/JOP.18.00115.

QC measures improve with CMS Oncology Care Model, Rocque G et al. J Oncol Pract. 2019. doi: 10. 1200/JOP.18.00390.

Must Reads in Renal Cell Carcinoma

First-line avelumab/axitinib for RCC benefits wide range of patients, Choueiri TK et al. GUCS 2019, Abstract 544.

Strong link found between RCC and melanoma, Kim KB et al. Cancer Epidemiol. 2018 Oct 19;57:80-4

Apo B/A1 predicts survival in metastatic renal cell carcinoma, Zhang F et al. Urol Oncol. 2018 Nov 30. doi: 10.1016/j.urolonc.2018.11.010

RCC patients with brain-only metastases may benefit from cytoreductive nephrectomy, Daugherty M et al. Urol Oncol. 2018 Dec 5.doi: 10.1016/j.urolonc.2018.10.021

Lower concentration of pazopanib linked with less toxicity, Noda S et al. Clin Genitourin Cancer. 2018 Dec 7. doi: 10.1016/j.clgc.2018.12.001